ArticleFrontiers in medicine2026
Comparison of myopia control efficacy between single vision and highly aspherical Lenslet spectacle lenses in children with low myopia: a 1-year retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the effectiveness of Single Vision Lenses (SVL) and Highly Aspherical Lenslets (HAL) lenses in the management of low myopia. Methods: This retrospective study included school-age children (aged 6-12 years) diagnosed with low myopia who were treated at Chengdu Third People's Hospital from January 2022 to August 2025. Patients were divided into two groups based on their myopia control intervention: the SVL group and the HAL group. Subgroup analyses were subsequently performed within both groups according to age. The progression in mean spherical equivalent refraction (SER) and axial length (AL) was compared among the different groups and subgroups. Results: A total of 157 children (87 males [55.41%] and 70 females [44.59%]) with myopia (right eye only, 157 eyes), aged 6-12 years (mean age, 8.94 ± 1.39 years), were included. The SVL group comprised 49 cases (49 eyes) with an average progression in SER (ΔSER) of -0.70 ± 0.45 D and an average axial length increase (ΔAL) of 0.31 ± 0.19 mm. The HAL group comprised 108 cases (108 eyes) with an average ΔSER of -0.18 ± 0.38 D and an average ΔAL of 0.13 ± 0.16 mm. Within the HAL subgroups, the median ΔAL in the 7-year group was significantly higher than in the 8-year ( Conclusion: Single-vision lenses provide only minimal control of myopia progression, whereas specially designed lenses such as HAL lenses effectively slow myopia development-especially by curbing axial elongation. Age is also a critical factor: even with HAL lenses, axial growth remains pronounced in children under 8 years and is more difficult to control. For those who develop myopia at a younger age, combined pharmacological interventions may offer a better strategy than optical correction alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.